Gulf Pharmaceutical Industries (JULPHAR)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

News

14 August 04:21 PM Julphar turns into profitability in H1-25 backed by operations in Egypt

Abu Dhabi - Mubasher: Gulf Pharmaceutical Industries (Julphar) swung to profitability at AED 158.20 million in the first half (H1) of 2025, against net losses of AED 2.40 million in H1-24. Basic and diluted earnings per share stood at 13.70 fils …

Financial Results

17 November 2024 10:55 AM Julphar’s drives portfolio progress in MENA with 14% higher sales in 9M-24

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) recorded sales valued at AED 1.30 billion in the first nine months (9M) of 2024, higher by 14% year-on-year (YoY) than AED 1.22 billion. The ADX-listed frim posted lower net losses at …

Global Economy

18 August 2024 00:13 PM Julphar sees lower net losses in H1-24; revenues up 3%

Abu Dhabi – Mubasher: The net losses of Gulf Pharmaceutical Industries (Julphar) retreated to AED 2.40 million in the first half (H1) of 2024 from AED 45.70 million in H1-23. The revenues from contracts with customers stood at AED 883.10 million …

Financial Results

15 May 2024 10:37 AM Julphar turns profitable in Q1-24; accumulated losses announced

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) logged net profits attributable to the owners amounting to AED 1.90 million in the first quarter (Q1) of 2024. The registered profits were compared to net losses worth AED 2.90 million …

Financial Results

17 March 2024 01:28 PM Julphar’s 2023 accumulated losses hit 30% of capital; revenues up

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) registered accumulated losses valued at AED 346.70 million as of 31 December 2023. The incurred accumulated losses represent 30% of the company’s paid-up capital, according to a bourse …

Financial Results

13 November 2023 01:47 PM Julphar turns to losses in 9M-23; accumulated losses reach 29% of capital

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) shifted to net losses attributable to the equityholders amounting to AED 83.40 million in the first nine months (9M) of 2023. The negative results were compared to net profits worth …

Financial Results

14 August 2023 11:53 AM Julphar unveils H1-23 financials; accumulated losses hit AED 295.5m

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) swung to net losses attributable to the owners valued at AED 44.10 million in the first half (H1) of 2023, versus profits of AED 6.30 million in H1-22. The revenues from contracts with …

Financial Results

17 May 2023 09:26 AM Julphar shifts to losses in Q1-23; accumulated losses unveiled

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) turned to net losses attributable to the shareholders worth AED 2.90 million in the first quarter (Q1) of 2023. The incurred net losses were against profits valued at AED 1.50 million …

Financial Results

9 February 2023 06:03 PM Julphar’s CEO resigns; Ziyadeh assumes position

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) announced, on 9 February, the resignation of Essam Mohamed from his position as the CEO of the company. Julphar elaborated that Mohamed left the firm as he will join another company, …

Board of Directors

10 November 2022 05:07 PM Julphar’s profits to equityholders shrink to AED 10.5m in 9M-22

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) logged net profits attributable to the owners worth AED 10.40 million in the first nine months (9M) of 2022, down from AED 103.20 million in 9M-21. Revenue from contracts with …

Financial Results

16 May 2022 09:41 AM Julphar turns to profitability in Q1-22

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has achieved net profits attributable to the equity holders of AED 1.5 million in the first quarter (Q1) of 2022, against net losses of AED 23.9 million in the same quarter of 2021, …

Financial Results

20 March 2022 10:09 AM Julphar turns to profitability in 2021

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has achieved net profits attributable to the equity holders of AED 64.4 million in 2021, against net losses of AED 293.2 million in 2020, according to the company's consolidated …

Financial Results

6 December 2021 10:19 AM Julphar inks exclusive license, production agreement with France's Quantum Genomics

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has reached an exclusive license and production agreement with Quantum Genomics, a France-based biopharmaceutical company, to market and produce firibastat. Through its manufacturing …

Companies Investments

28 November 2021 09:38 AM Julphar logs AED 183m accumulated losses

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has incurred accumulated losses of AED 183.1 million as of the third quarter (Q3) of 2021, representing 16% of the capital. The losses are driven by the temporary suspension of export …

Financial Results

5 September 2021 04:23 PM Julphar sells 100% subsidiary Dubai-based Gulf Inject

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has entered into an agreement to sell its wholly-owned subsidiary, Dubai-based Gulf Inject, to GlobalOne Healthcare Holding, the healthcare division of Yas Holding in Abu Dhabi. The …

Companies Investments

15 August 2021 03:58 PM Julphar turns profitable in H1-21

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) registered AED 49.9 million in profits during the first half (H1) of the year, compared with losses of AED 83.2 million in H1-20. The company attributed turning profitable to the …

Financial Results

13 July 2021 04:12 PM Julphar fully acquires Planet Pharmacies

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has entered into an agreement to fully acquire Planet Pharmacies, one of the leading pharmaceutical distributors in the UAE, Saudi Arabia, and the Sultanate of Oman. Julphar, which …

Companies Investments

16 June 2021 04:18 PM Julphar sells 51% stake in Alpha Pharma

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has sold its 51% stake in Alpha Pharma. Expected to be completed in the third quarter (Q3) of 2021, the transaction is expected to reduce 10% to 12% of Julphar's consolidated total …

Companies Investments

29 March 2021 10:29 AM Julphar inks agreement to manufacture COVID-19 vaccines from Sinopharm

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has entered into a manufacturing agreement with G42 Medications Trading to produce the coronavirus (COVID-19) vaccines from China's Sinopharm. The commercial production of the …

Companies Investments

12 August 2020 09:54 AM Julphar logs AED 83m accumulated losses

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) posted AED 83.2 million accumulated losses as of the end of the second quarter (Q2) of 2020, representing 12.7% of the capital. The accumulated losses are driven by the temporary …

Financial Results

15 July 2020 02:03 PM Julphar's rights issue oversubscribed 2.3 times

Abu Dhabi – Mubasher: The AED 500 million rights issue of Gulf Pharmaceutical Industries (Julphar) has been oversubscribed 2.3 times to settle at AED 1.14 billion on application which closed on 12 July. The net proceeds from the rights issue will …

Corporate Actions

1 June 2020 11:36 AM Julphar launches AED 500m rights issue to improve capital profile

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has launched a rights issue to raise AED 500 million and improve its capital position and debt profile. By raising AED 500 million, the company will finance its turnaround plan and put …

Banking and Finance

27 May 2020 04:20 PM Julphar’s loss down 30% in Q1-20; accumulated losses at AED 566m

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) incurred AED 62.5 million in net losses attributable to shareholders during the first quarter of 2020, down from AED 89.1 million in the year-ago period. Net sales fell to AED 114.6 …

Financial Results

30 April 2020 00:06 PM Julphar to resume exports to Saudi Arabia after two-year suspension

Abu Dhabi – Mubasher: The Saudi Food and Drug Authority (SFDA) has lifted the temporary suspension on the exports of Gulf Pharmaceutical Industries (Julphar) to Saudi Arabia. Following a ban for 20 months, Julphar's exports to Saudi Arabia will be …

Companies Investments

9 April 2020 10:39 AM Julphar to extinguish accumulated losses via capital cut

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) plans to decrease the share capital by AED 503.274 million by canceling a number of the company's shares. With the capital reduction, Julphar seeks to write off accumulated losses …

Corporate Actions